Mary Chapman,  —

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d'Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled "Belle of the Concours."

Articles by Mary Chapman

6 young scientists awarded LFA fellowship grants for lupus research

The six recipients of Lupus Foundation of America (LFA)’s 2024 fellowships for young scientists will use their awards to study several areas of lupus, ranging from lupus nephritis to the connection between physical activity and physical function in people with the autoimmune disease. The goal of the 40-year-old…

Cullinan developing treatment for lupus, other autoimmune diseases

Note: This story was updated May 6, 2024, to correct that Cullinan Therapeutics continues to pursue its oncology platform while also expanding into treatments for autoimmune diseases including lupus. Cullinan Therapeutics has announced its plans to exclusively pursue the development of its T-cell-engager CLN-978 as a treatment for…

Shared stories and outreach to mark May, Lupus Awareness Month

For this Lupus Awareness Month, marked each May, the focus is on educating people about the autoimmune disorder thought to affect about 1.5 million U.S. residents and more than 5 million individuals globally. World Lupus Day, bringing disease warriors worldwide together, will be observed on May…

FibroBiologics files for US patent of fibroblast technology to treat lupus

FibroBiologics, a biopharmaceutical company that seeks to develop and commercialize fibroblast cell-based therapies, has filed an application with the United States Patent and Trademark Office covering the use of its technology to potentially treat lupus. Using its proprietary fibroblast platform, the Houston-based company aims to develop cures…

New MyLupus mobile phone app aims to help in healthcare decisions

MyLupus, a new mobile phone app that’s meant to be used between doctor visits, was designed to help people with moderate to severe lupus make more-educated healthcare decisions. The free application was developed by a team of scientists — including rheumatologists at the University of Alabama at Birmingham (UAB)…

UC San Diego gifted $1.6M to enhance lupus research, care

A $1.6 million gift from business executive William J. Wolfe and his family will establish the Wolfe Lupus Research Fund at the University of California (UC) San Diego to advance lupus research and patient care. Wolfe, a longtime lupus community supporter, is a board member of the Lupus…